Author information:
(1)Scott N. Gettinger and Mario Sznol, Yale Cancer Center, New Haven, CT; Leora 
Horn, David P. Carbone, and Jeffrey A. Sosman, Vanderbilt University Medical 
Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, 
Nashville, TN; Leena Gandhi, David M. Jackman, and F. Stephen Hodi, Dana-Farber 
Cancer Institute; Rebecca S. Heist and Lecia V. Sequist, Massachusetts General 
Hospital Cancer Center; David F. McDermott, Beth Israel Deaconess Medical 
Center, Boston, MA; Scott J. Antonia and Mary C. Pinder-Schenck, H. Lee Moffitt 
Cancer Center and Research Institute, Tampa, FL; Naiyer A. Rizvi, Richard D. 
Carvajal, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New 
York, NY; John D. Powderly, Carolina BioOncology Institute, Huntersville, NC; 
David C. Smith, University of Michigan, Ann Arbor, MI; Philip Leming, Christ 
Hospital Cancer Center, Cincinnati, OH; Suzanne L. Topalian, Drew M. Pardoll, 
and Julie R. Brahmer, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 
Baltimore, MD; and Vindira Sankar, Christoph M. Ahlers, Mark Salvati, Jon M. 
Wigginton, Georgia D. Kollia, and Ashok K. Gupta, Bristol-Myers Squibb, 
Princeton, NJ. scott.gettinger@yale.edu.
(2)Scott N. Gettinger and Mario Sznol, Yale Cancer Center, New Haven, CT; Leora 
Horn, David P. Carbone, and Jeffrey A. Sosman, Vanderbilt University Medical 
Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, 
Nashville, TN; Leena Gandhi, David M. Jackman, and F. Stephen Hodi, Dana-Farber 
Cancer Institute; Rebecca S. Heist and Lecia V. Sequist, Massachusetts General 
Hospital Cancer Center; David F. McDermott, Beth Israel Deaconess Medical 
Center, Boston, MA; Scott J. Antonia and Mary C. Pinder-Schenck, H. Lee Moffitt 
Cancer Center and Research Institute, Tampa, FL; Naiyer A. Rizvi, Richard D. 
Carvajal, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New 
York, NY; John D. Powderly, Carolina BioOncology Institute, Huntersville, NC; 
David C. Smith, University of Michigan, Ann Arbor, MI; Philip Leming, Christ 
Hospital Cancer Center, Cincinnati, OH; Suzanne L. Topalian, Drew M. Pardoll, 
and Julie R. Brahmer, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 
Baltimore, MD; and Vindira Sankar, Christoph M. Ahlers, Mark Salvati, Jon M. 
Wigginton, Georgia D. Kollia, and Ashok K. Gupta, Bristol-Myers Squibb, 
Princeton, NJ.